Tedizolid Phosphate Patent Expiration
Tedizolid Phosphate is Used for treating acute bacterial skin and skin structure infections caused by susceptible bacteria. It was first introduced by Cubist Pharmaceuticals Llc
Tedizolid Phosphate Patents
Given below is the list of patents protecting Tedizolid Phosphate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Sivextro | US8426389 | Crystalline form of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate | Dec 31, 2030 | Cubist Pharms Llc |
| Sivextro | US10065947 | Forms of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate | Feb 03, 2030 | Cubist Pharms Llc |
| Sivextro | US10442829 | Forms of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate | Feb 03, 2030 | Cubist Pharms Llc |
| Sivextro | US9624250 | Forms of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate | Feb 03, 2030 | Cubist Pharms Llc |
| Sivextro | US9988406 | Forms of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate | Feb 03, 2030 | Cubist Pharms Llc |
| Sivextro | US7816379 | Oxazolidinone derivatives | Jun 20, 2028 | Cubist Pharms Llc |
| Sivextro | US8420676 | Oxazolidinone derivatives | Feb 23, 2028 | Cubist Pharms Llc |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Tedizolid Phosphate's patents.
Latest Legal Activities on Tedizolid Phosphate's Patents
Given below is the list recent legal activities going on the following patents of Tedizolid Phosphate.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 09 Mar, 2023 | US10442829 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 09 Mar, 2022 | US7816379 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 09 Feb, 2022 | US10065947 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 11 Nov, 2021 | US9988406 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 15 Sep, 2020 | US8426389 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 15 Sep, 2020 | US9624250 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 15 Sep, 2020 | US8420676 |
| Patent Term Extension Certificate Critical | 29 Jul, 2020 | US7816379 |
| Notice of Final Determination -Eligible | 13 Apr, 2020 | US7816379 |
| Notice of Final Determination -Eligible | 19 Feb, 2020 | US7816379 |
Tedizolid Phosphate's Family Patents
